We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Technology Offers Fast, Data-Driven Image Analysis of Echocardiogram Images

By MedImaging International staff writers
Posted on 01 Sep 2022
Image: The Echo:Prio cardiac imaging analysis application has received FDA clearance (Photo courtesy of Dyad Medical)
Image: The Echo:Prio cardiac imaging analysis application has received FDA clearance (Photo courtesy of Dyad Medical)

Echocardiograms are often the first step in diagnosing and developing a treatment plan for heart disease. The heart is the only organ in constant movement as it pumps blood throughout the body. When analyzing the left ventricle, any abnormal motion may be a sign of heart disease. Most imaging labs rely on visual detections of these abnormalities to diagnose and manage heart disease. This subjective process requires a complete view of the endocardium which is not always available. Furthermore, additional factors influencing image interpretations include operator skill level and variations in heart rates and cardiac loading, all of which may be addressed using automated analysis. Now, a new application offers fast, data-driven image analysis of echocardiogram images, making it an important decision-making support tool for index quantification of cardiac function and saving the clinician’s time in diagnosis and treatment-decision making.

Dyad Medical, Inc.’s (Boston, MA, USA) echocardiogram application called Echo:Prio is a part of the company’s complete cardiac platform named Libby. Libby Echo:Prio is embedded in the current workflow of imaging operators, physicians, and researchers. The Libby platform is cloud-based, offering users a secure way to use it from any location on any device. The AI-powered platform provides users an immediately-available second opinion when diagnosing cardiac images saving them critical time that can be spent with patients. Echo:Prio has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA).

“The current process of manual echocardiographic assessment of myocardial function is time consuming and lacks consistency between readings. The FDA’s clearance of Dyad Medical’s Echo:Prio application allows us to provide operators and physicians an essential computer-assisted tool for echocardiographic analysis. Our solution is proven to be consistent and can be used across all systems, regardless of an operator’s skill level,” said Dr. Ronny Shalev, CEO and co-Founder of Dyad Medical, Inc. “Dyad Medical’s Echo:Prio application allows physicians to prioritize patient treatments and deliver the life-saving care needed for those who need it most. Echocardiogram analysis done manually is time consuming and must be done consistently across all patients and operators. Echo:Prio is expanding the physician’s view so they have greater confidence in their diagnosis leading to greater patient satisfaction and retention.”

 

 

Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Digital Radiography System (Ceiling Free)
Digix CF Series
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Mobile X-Ray System
K4W

Channels

General/Advanced Imaging

view channel
Image: A multinational study reports that AI can quickly generate clinically acceptable radiotherapy plans across care settings (Photo courtesy of Adobe Stock)

AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer

Cervical cancer causes most of its global mortality in low- and middle-income countries, where radiotherapy capacity and specialist staff are limited. Treatment planning is labor-intensive and can delay... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.